I am late to my own party, but I wanted to write a short 🧵 to put this talk in context. First of all, the TED Talks team was amazing; there is so much that goes into these seemingly short talks. It was an amazing experience and I made some new friends. ted.com/talks/hani_goo…

My time at 50Y and with 5050 was transformative. From pushing our academic research into products, hiring an amazing team, and storytelling - I cannot recommend this enough if you want to learn about how to take the first steps out of academia and into becoming a founder.

Excited to share "Multiplexed Effector Guide Arrays" (MEGA) tech, led by Victor Tieu Victor Tieu & collaboration with Dr. Crystal Mackall, in Cell Cell. A leap in T cell transcriptome & metabolic engineering for cancer therapy. Congrats to team! authors.elsevier.com/a/1ie1VL7PXqPm4

Really excited about a new position for our first dedicated ChemML/AI person at Octant. Our HT-Chem platform is really humming, and we are very excited to bring generative approaches in the loop to drive subsequent iterations on the platform. Posting: octant.bio/jobs?gh_jid=50…

wow!! thank you ACIR & lauren hitchings for the wonderful writeup and visual summary of our work!!

We’re excited to host a webinar with Elsie Biotechnologies, industry leader and GSK’s partner in oligonucleotide drug discovery, on how to engineer oligonucleotide therapies at unprecedented scale. Register to join us on March 21st to learn more: latch.bio/customer-scien…

I'm excited to share our work "Structural insights reveal interplay between LAG-3 homodimerization, ligand binding, and function" that's now out in PNAS! 1/3 Link to paper: pnas.org/doi/10.1073/pn… Link to press release: news.stanford.edu/2024/03/11/pro…

ML models like Evo + AlphaFold are emerging to engineer molecules. It is sometimes unclear how to use these tools to build drugs. We trace a realistic design, build and test loop of virus capsids on LatchBio.

Check out this new preprint/white paper from our friends at Entwine bio together with Vishnu Ram and Zaro Lab. We and others have long been interested in sequence-to-function modeling in RNA, especially as it comes to splicing. biorxiv.org/content/10.110…

Spring Quarter is a season of renewal and growth, both in nature and within our lab :) Welcoming new lab members! We are also looking for new postdocs interested in engineering synthetic cells for biomedical applications. #synbio #UCDavisBME #BME

Introducing SF Deep Tech Week When people think of SF they think of software startups. But SFBA is also the deep tech capital of the world. Time to show off with events on bio, industrials, defense, energy, climate, space, quantum. Oh, and parties.

Shouldn’t aging be part of drug discovery for diseases of aging? gordian.bio/blog/introduci… Gordian exists to move therapeutic testing from plastic wells and young mice into a living environment with all the complexity present in patients with age-related disease. We’re now

Kits are a key part of the increased pace of biological discovery. Protocols that 10 years ago took a team of scientists months of work can now be ordered online and done in a few hours! But there is a massive problem plaguing these kits and ruining the beautiful abstraction:

latch is focusing efforts on building a world class platform to distribute and analyze protein + genetic sequencing kit data progress in engineering biology is bottlenecked by tools blog.latch.bio/p/a-bioinforma…

Today we announce the close of a $26M Series A financing, led by Radical Ventures with participation from all existing investors, and pharmaceutical collaborations with AstraZeneca, Bristol Myers Squibb, and Takeda. Thanks to Endpoints News for breaking our news. endpts.com/exclusive-astr…

Excited to share Nabla Bio is partnering with 3 of the world’s largest pharma cos to use integrated AI and wet-lab tech to design antibodies against challenging disease targets. Thrilled to also add Radical Ventures who led our $26M Series A to the family! bit.ly/4dDk4lP

The world needs 10x more scientist-founders. 5050 helps scientists and engineers become great founders and start indispensable companies. Applications open! Startups are the best way to make a real impact with research, but where do you get started? How do you know if

Much love for my friends Fifty Years. Some of the few people I know whose energy can turn offhand jokes into making my mom mad.

In this episode of Turpentine VC, Erik Torenberg sat down with Seth Bannon, co-founder and general partner at Fifty Years, a pre-seed and seed-focused VC firm. They discuss the challenges of commercializing academic research, the differences between biotech and tech bio

London! I'll be in town for 2 months starting next week with e/la and Ale Borda. Why? Big announcement soon 🤫 Who should we meet? Scientists, founders, angel investors, connectors -- let us know! Have a place for Oct but where should we stay in November? Tips welcome!